$4.30
-0.24[-5.29%]
At close: Apr 24
$4.30
0[0.00%]
After Hours: 4:03PM EDT
Fate Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Fate Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | PM | FATE | Q1 | -$0.19 | -$0.50 | — | — | $58.98M | $1.22M | — | — | Get Alert |
02/26/2024 | PM | FATE | Q4 | -$0.58 | -$0.52 | -$0.45 | 13.46% | $44.36M | $1.59M | $1.68M | 5.41% | Get Alert |
11/08/2023 | PM | FATE | Q3 | -$0.86 | -$0.57 | -$0.46 | 19.30% | $14.98M | $890.00K | $1.94M | 118.43% | Get Alert |
08/08/2023 | PM | FATE | Q2 | -$0.79 | -$0.59 | -$0.54 | 8.47% | $18.55M | $5.53M | $933.00K | -83.13% | Get Alert |
05/03/2023 | PM | FATE | Q1 | -$0.68 | -$0.62 | -$0.19 | 69.35% | $18.41M | $35.50M | $58.98M | 66.14% | Get Alert |
02/28/2023 | PM | FATE | Q4 | -$0.72 | -$0.86 | -$0.58 | 32.56% | $17.07M | $16.72M | $44.36M | 165.29% | Get Alert |
11/03/2022 | PM | FATE | Q3 | -$0.45 | -$0.89 | -$0.86 | 3.37% | $14.22M | $15.63M | $14.98M | -4.15% | Get Alert |
08/03/2022 | PM | FATE | Q2 | -$0.58 | -$0.82 | -$0.79 | 3.66% | $13.41M | $12.91M | $18.55M | 43.68% | Get Alert |
05/04/2022 | PM | FATE | Q1 | -$0.48 | -$0.76 | -$0.68 | 10.53% | $11.14M | $9.40M | $18.41M | 95.89% | Get Alert |
02/28/2022 | PM | FATE | Q4 | -$0.61 | -$0.67 | -$0.72 | -7.46% | $15.90M | $10.73M | $17.07M | 59.06% | Get Alert |
11/04/2021 | PM | FATE | Q3 | -$0.68 | -$0.58 | -$0.45 | 22.41% | $7.56M | $7.89M | $14.22M | 80.29% | Get Alert |
08/04/2021 | PM | FATE | Q2 | -$0.35 | -$0.53 | -$0.58 | -9.43% | $5.46M | — | $13.41M | — | Get Alert |
05/05/2021 | PM | FATE | Q1 | -$0.44 | -$0.43 | -$0.48 | -11.63% | $2.52M | $5.90M | $11.14M | 88.85% | Get Alert |
02/24/2021 | PM | FATE | Q4 | -$0.37 | -$0.39 | -$0.61 | -56.41% | $2.80M | $4.87M | $15.90M | 226.41% | Get Alert |
11/05/2020 | PM | FATE | Q3 | -$0.40 | -$0.36 | -$0.68 | -88.89% | $2.43M | $6.97M | $7.56M | 8.44% | Get Alert |
08/05/2020 | PM | FATE | Q2 | -$0.36 | -$0.27 | -$0.35 | -29.63% | $2.82M | $13.23M | $5.46M | -58.69% | Get Alert |
05/11/2020 | PM | FATE | Q1 | -$0.30 | -$0.39 | -$0.44 | -12.82% | $2.63M | $1.80M | $2.52M | 39.72% | Get Alert |
03/02/2020 | PM | FATE | Q4 | -$0.25 | -$0.39 | -$0.37 | 5.13% | $1.66M | $1.80M | $2.80M | 55.67% | Get Alert |
11/05/2019 | PM | FATE | Q3 | -$0.31 | -$0.38 | -$0.40 | -5.26% | $1.03M | $1.79M | $2.43M | 35.70% | Get Alert |
Fate Therapeutics (FATE) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 26, 2024 for Q4.
The Actual EPS was $-0.45, which beat the estimate of $-0.52.
The Actual Revenue was $1.7M, which beat the estimate of $1.6M.
Browse earnings estimates, EPS, and revenue on all stocks.